Slideset: Early Induction Therapy for IBD

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.
Bruce E. Sands, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 581 KB
Released: April 26, 2021

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Related Content

Expert commentary from Dr. Bruce Sands on STRIDE-II recommendations for treat-to-target goals in IBD, from Clinical Care Options (CCO)

Bruce E. Sands, MD, MS Released: May 5, 2021

Interactive video from Dr. Bruce Sands and Clinical Care Options (CCO): treatment guidelines for UC and CD

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: April 26, 2021 Expired: April 25, 2022

Clinical Care Options (CCO) expert commentary on new data on IBD pathogenesis and management from the 2021 virtual Crohn’s & Colitis Congress

Anita Afzali, MD, MPH, FACG Released: March 5, 2021

Expert commentary from Raymond K. Cross, MD, MS, on management of moderate to severe ulcerative colitis, as reported to Clinical Care Options (CCO)

Raymond K. Cross, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 14, 2020 Expired: December 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue